Business Description
![Syneos Health Inc Syneos Health Inc logo](https://static.gurufocus.com/logos/0C0000AR3G.png?12)
Syneos Health Inc
NAICS : 541714
SIC : 8731
ISIN : US87166B1026
Share Class Description:
FRA:8IN: Class ADescription
Syneos is a global contract research and outsourced commercialization organization that provides services to pharmaceutical and biotechnology firms. Its clinical solutions segment offers early- to late-stage clinical trial support that ranges from specialized staffing models to strategic partnerships that oversee nearly all aspects of a drug program, while the company's commercialization solutions includes outsourced sales, consulting, public relations, and advertising services.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | 0.43 | |||||
Debt-to-Equity | 0.83 | |||||
Debt-to-EBITDA | 6.26 | |||||
Interest Coverage | 3.08 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.44 | |||||
Beneish M-Score | -2.46 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.1 | |||||
3-Year EBITDA Growth Rate | 13.1 | |||||
3-Year EPS without NRI Growth Rate | 29.4 | |||||
3-Year FCF Growth Rate | 11.7 | |||||
3-Year Book Growth Rate | 6.9 | |||||
Future 3-5Y EPS without NRI Growth Rate | 1.27 | |||||
Future 3-5Y Total Revenue Growth Rate | 0.75 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 93.12 | |||||
9-Day RSI | 79.73 | |||||
14-Day RSI | 71.15 | |||||
6-1 Month Momentum % | 23.2 | |||||
12-1 Month Momentum % | -20.83 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.2 | |||||
Quick Ratio | 1.2 | |||||
Cash Ratio | 0.05 | |||||
Days Sales Outstanding | 60.46 | |||||
Days Payable | 10.7 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.3 | |||||
Shareholder Yield % | 0.72 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 22.18 | |||||
Operating Margin % | 6.4 | |||||
Net Margin % | 1.43 | |||||
FCF Margin % | 3.12 | |||||
ROE % | 2.26 | |||||
ROA % | 0.95 | |||||
ROIC % | 4.03 | |||||
ROC (Joel Greenblatt) % | 50.64 | |||||
ROCE % | 3.15 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 56.1 | |||||
Forward PE Ratio | 11.51 | |||||
PE Ratio without NRI | 56.1 | |||||
Shiller PE Ratio | 40.36 | |||||
Price-to-Owner-Earnings | 38.76 | |||||
PEG Ratio | 2.24 | |||||
PS Ratio | 0.8 | |||||
PB Ratio | 1.29 | |||||
Price-to-Free-Cash-Flow | 25.54 | |||||
Price-to-Operating-Cash-Flow | 16.64 | |||||
EV-to-EBIT | 35.5 | |||||
EV-to-Forward-EBIT | 13.28 | |||||
EV-to-EBITDA | 16.12 | |||||
EV-to-Forward-EBITDA | 10.04 | |||||
EV-to-Revenue | 1.33 | |||||
EV-to-Forward-Revenue | 1.38 | |||||
EV-to-FCF | 42.71 | |||||
Price-to-Projected-FCF | 0.82 | |||||
Price-to-DCF (Earnings Based) | 1.8 | |||||
Price-to-DCF (FCF Based) | 0.82 | |||||
Price-to-Peter-Lynch-Fair-Value | 4.5 | |||||
Earnings Yield (Greenblatt) % | 2.82 | |||||
FCF Yield % | 3.82 | |||||
Forward Rate of Return (Yacktman) % | 18.98 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Syneos Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 5,161.442 | ||
EPS (TTM) (€) | 0.713 | ||
Beta | 0 | ||
Volatility % | 47.76 | ||
14-Day RSI | 71.15 | ||
14-Day ATR (€) | 0.187267 | ||
20-Day SMA (€) | 39.38 | ||
12-1 Month Momentum % | -20.83 | ||
52-Week Range (€) | 25.665 - 51.08 | ||
Shares Outstanding (Mil) | 103.72 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Syneos Health Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Syneos Health Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Syneos Health Inc Frequently Asked Questions
What is Syneos Health Inc(FRA:8IN)'s stock price today?
The current price of FRA:8IN is €40.00. The 52 week high of FRA:8IN is €51.08 and 52 week low is €25.67.
When is next earnings date of Syneos Health Inc(FRA:8IN)?
The next earnings date of Syneos Health Inc(FRA:8IN) is 2024-05-10 Est..
Does Syneos Health Inc(FRA:8IN) pay dividends? If so, how much?
Syneos Health Inc(FRA:8IN) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |